These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27366711)

  • 21. Mineral and bone disorder in hemodialysis patients in the Tibetan Plateau: a multicenter cross-sectional study.
    Dang ZH; Tang C; Li GL; Luobu C; Qing D; Ma ZH; Qu JF; Suolang L; Liu LJ
    Ren Fail; 2019 Nov; 41(1):636-643. PubMed ID: 31269846
    [No Abstract]   [Full Text] [Related]  

  • 22. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D Therapy in Adults With CKD: A Systematic Review and Meta-analysis.
    Yeung WG; Palmer SC; Strippoli GFM; Talbot B; Shah N; Hawley CM; Toussaint ND; Badve SV
    Am J Kidney Dis; 2023 Nov; 82(5):543-558. PubMed ID: 37356648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of parathyroidectomy on bone remodeling markers and vitamin D status in patients with chronic kidney disease-mineral and bone disorder.
    Peters BS; Moyses RM; Jorgetti V; Martini LA
    Int Urol Nephrol; 2007; 39(4):1251-6. PubMed ID: 17680337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
    Jean G; Daugas É; Roth H; Drueke T; Bouchet JL; Hannedouche T; London G; Fouque D
    Nephrol Ther; 2017 Nov; 13(6):470-478. PubMed ID: 28843391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D levels and other biochemical parameters of mineral bone disorders and their association with diastolic dysfunction and left ventricular mass in young nondiabetic adult patients with chronic kidney disease.
    Sonkar SK; Bhutani M; Sonkar GK; Pandey SK; Chandra S; Bhosale V
    Saudi J Kidney Dis Transpl; 2017; 28(4):758-763. PubMed ID: 28748877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and pattern of chronic kidney disease-mineral bone disorders among hemodialysis patients in kano, northwest nigeria.
    Abdu A; Abdu A; Arogundade FA
    Ann Afr Med; 2019; 18(4):191-195. PubMed ID: 31823953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing Spectrum of Mineral Bone Disorder in Chronic kidney disease stage 3 to 5 D and Its Associated Factors, A Prospective Cross-Sectional Study from Tertiary Care Hospital in Northern India.
    Sethi S; Sethi N; Sandhu JS; Makkar V; Kaur S; Sohal PM; Mehta S
    Iran J Kidney Dis; 2021 May; 15(3):199-205. PubMed ID: 33994379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of triangle grass decoction on bone metabolism in rats with chronic kidney disease complicated with mineral and bone abnormalities.
    Liu L; Wang L; Li L; Wang H; Yuan L; Kang L; Jiang Q; Chen G; Lv N; Cui X; Huang L; Wu H; Xu J; Li Y
    J Ethnopharmacol; 2021 Jul; 275():114126. PubMed ID: 33872749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters.
    Roetker NS; Peng Y; Ashfaq A; Gilbertson DT; Wetmore JB
    Am J Nephrol; 2019; 49(3):225-232. PubMed ID: 30820015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism.
    Block GA; Zeig S; Sugihara J; Chertow GM; Chi EM; Turner SA; Bushinsky DA;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2311-8. PubMed ID: 18310602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical markers of mineral bone disorder in South African patients on maintenance haemodialysis.
    Waziri B; Duarte R; Naicker S
    Afr Health Sci; 2017 Jun; 17(2):445-452. PubMed ID: 29062340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D insufficiency and deficiency in children with chronic kidney disease.
    Kari JA; El Desoky SM; El-Morshedy SM; Habib HS
    Ann Saudi Med; 2012; 32(5):473-8. PubMed ID: 22871615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience.
    Liangos O; Kirchhoff S; Buchholz J; Ketteler M
    Kidney Blood Press Res; 2018; 43(4):1222-1230. PubMed ID: 30071519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D deficiency in chronic kidney disease: Myth or reality?
    Priyadarshini G; Parameswaran S; Sahoo J; Selvarajan S; Rajappa M
    Clin Chim Acta; 2021 Dec; 523():35-37. PubMed ID: 34480954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of prevalence, biochemical profile, and drugs associated with chronic kidney disease-mineral and bone disorder in 11 dialysis centers.
    Abrita RR; Pereira BDS; Fernandes NDS; Abrita R; Huaira RMNH; Bastos MG; Fernandes NMDS
    J Bras Nefrol; 2018; 40(1):26-34. PubMed ID: 29796575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor-alpha is associated with mineral bone disorder and growth impairment in children with chronic kidney disease.
    Meza K; Biswas S; Zhu YS; Gajjar A; Perelstein E; Kumar J; Akchurin O
    Pediatr Nephrol; 2021 Jun; 36(6):1579-1587. PubMed ID: 33387018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Therapies for Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Chronic Kidney Disease.
    Strugnell SA; Csomor P; Ashfaq A; Bishop CW
    Kidney Dis (Basel); 2023 May; 9(3):206-217. PubMed ID: 37497207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
    Del Valle E; Negri AL; Aguirre C; Fradinger E; Zanchetta JR
    Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.